Study of T Specific Immune Response Against Delta-CD20 Peptide in Hematological Malignancies B

NCT02844491 · clinicaltrials.gov ↗

TERMINATED

Status

28

Enrollment

OTHER

Sponsor class

Stopped Difficulty of recruiting

Conditions

Hematological Malignancies B

Interventions

OTHER: additional biological samples

Sponsor

Centre Hospitalier Universitaire de Besancon